![](https://cdn.sanity.io/images/0vv8moc6/neurolive/78c731a097474d41274d51a61dc9b18d52d08b79-300x300.png?fit=crop&auto=format)
New Investigator-Initiated Study to Test CYR-064 for Hyposmia in Parkinson Disease
Cryano Therapeutics recently announced the initiation of a new investigator-initiated study (NCT06498687) testing the effects of investigational CYR-064 on hyposmia, or the loss of smell, in patients with Parkinson disease (PD). Hyposmia, one of the most …